NIH Director Francis Collins on COVID-19 vaccine development: “There’s nothing political about what we’re trying to do here. We’re just trying to find those answers as fast as we can.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
U.S. government begins two trials testing Eli Lilly's coronavirus antibody drugThe trials, called ACTIV-2 and ACTIV-3, will look at U.S. drugmaker Eli Lilly's experimental treatment known as LY-CoV555, which is being developed in partnership with Canadian biotech AbCellera.
続きを読む »
Eli Lilly Studies Experimental Covid-19 Drug in Nursing HomesThe late-stage trial is exploring whether Eli Lilly’s antibody drug can help reduce infections in senior facilities with a diagnosed case of the new coronavirus.
続きを読む »
U.S. to Launch Covid-19 Drug Research Starting With Eli Lilly TreatmentThe National Institutes of Health said it is launching wide-ranging studies of potential drugs to treat Covid-19 beginning with a monoclonal antibody drug from Eli Lilly & Co. called LY-CoV555.
続きを読む »
Lilly begins nursing home trials with antibody drug for COVID-19 preventionUS drugmaker Eli Lilly & Co. says it is beginning a late-stage trial to study whether one of its experimental COVID-19 antibody treatments can prevent the virus' spread in residents and staff in nursing homes.
続きを読む »
Trial started for COVID-19 antibody treatment to prevent serious illnessWhile treatments such as remdesivir and dexamethasone can help very ill patients, there's a need for treatments that work in more mild cases.
続きを読む »
US launches advanced trials to test antibody treatment for Covid-19The National Institutes of Health has announced that it is launching two advanced trials to test monoclonal antibodies in patients with Covid-19, one for patients with mild disease and another for patients who are hospitalized
続きを読む »